Live Breaking News & Updates on Active controlled study evaluating

Moderna : 2024 ESCMID (mRNA-1010) - MarketScreener

Safety and Immunogenicity of an mRNA-Based

Seasonal Influenza Vaccine in Healthy Adults

Mieke Soens, Raffael.

Spain , United-states , Barcelona , Comunidad-autonoma-de-cataluna , American , Jintanat-ananworanich , Raffael-nachbagauer , Angela-choi , Kristi-schaefers , Andrei-avanesov , Dolgine-nat , Aliscia-daniels

Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns

22.12.2021 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials in all ongoing clinical studies for HIV treatment and HIV . Seite 1

Ihre-einsch , Merdad-parsey , Gilead-sciences , Drug-administration , Gilead-sciences-inc , Nasdaq , Sie-ihre-einsch , Beachten-sie , Chief-medical-officer , Long-acting-capsid-inhibitor , Optimized-background-regimen